JP MORGAN/CALL/ABBOTT LABORATORIES/155/0.1/20.06.25 Stock

Warrant

DE000JK4TTM3

Real-time Bid/Ask 07:55:26 2024-06-05 EDT
0.02 EUR / 0.06 EUR +100.00% Intraday chart for JP MORGAN/CALL/ABBOTT LABORATORIES/155/0.1/20.06.25
Current month-23.08%
1 month-66.67%
Date Price Change
24-06-04 0.02 -4.76%
24-06-03 0.021 -19.23%
24-05-31 0.026 -3.70%
24-05-30 0.027 +17.39%
24-05-29 0.023 -28.12%

Delayed Quote Börse Stuttgart

Last update June 04, 2024 at 04:39 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer J.P. Morgan
WKN JK4TTM
ISINDE000JK4TTM3
Date issued 2024-03-15
Strike 155 $
Maturity 2025-06-20 (380 Days)
Parity 10 : 1
Emission price 0.27
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.26
Lowest since issue 0.02
Spread 0.04
Spread %67.80%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
103.4 USD
Average target price
125.4 USD
Spread / Average Target
+21.22%
Consensus